Sign In
Buy DOCS
$21.04
-0.470 (-2.19%)
At Close: Jun 03, 2026
Doximity (DOCS) Laps the Stock Market: Here's Why
07:16pm, Friday, 27'th Jun 2025
Doximity (DOCS) concluded the recent trading session at $61.09, signifying a +1.13% move from its prior day's close.
Does DOCS' Shift Toward Enterprise Offerings Signal a Long-Term Pivot?
09:51am, Thursday, 26'th Jun 2025
DOCS sharpens its enterprise focus with AI and workflow tools, signaling a deeper pivot beyond pharma marketing roots.
Will AI Tools Like DocsGPT Drive the Next Leg of Growth for DOCS?
09:26am, Friday, 20'th Jun 2025
DOCS is leaning on AI tools like Doximity GPT to fuel growth after a strong FY25, but monetization remains early-stage.
DOCS vs. IRTC: Who Will Win High-Stakes AI Showdown in Digital Health?
08:26am, Thursday, 19'th Jun 2025
DOCS and IRTC are redefining digital health with AI, but only one is winning big with investors in 2025's market surge.
Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'
07:18am, Wednesday, 18'th Jun 2025
I rate Doximity a 'Buy' with a $62 fair value, citing its dominant network among U.S. healthcare professionals and robust growth trajectory. Doximity's strong pharma marketing business, workflow solut
OGN or DOCS: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 17'th Jun 2025
Investors looking for stocks in the Medical Services sector might want to consider either Organon (OGN) or Doximity (DOCS). But which of these two stocks presents investors with the better value oppor
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
10:35am, Thursday, 12'th Jun 2025
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fi
DOCS Boosts Client Retention via Workflow Integration and AI Tools
11:31am, Wednesday, 11'th Jun 2025
Doximity strengthens client loyalty by embedding AI tools and clinical workflows into its platform for medical professionals.
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
12:20pm, Monday, 09'th Jun 2025
NEW YORK , June 9, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fidu
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm
03:45pm, Friday, 06'th Jun 2025
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fi
Doximity Declines 4.4% in a Month: How to Play the Stock Now?
12:46pm, Thursday, 05'th Jun 2025
Over the past month, Doximity's DOCS shares have lost approximately 4.4% despite the company reporting solid fourth-quarter fiscal 2025 results with $138.3 million in revenues and a 50% adjusted EBITD
Dr Martens surges 23% as investors lace up for recovery story
10:50am, Thursday, 05'th Jun 2025
Shares in Dr Martens PLC (LSE:DOCS) jumped 23% on Thursday after the bootmaker delivered a better-than-expected full-year update and signalled a shift towards stabilisation and future growth, giving i
Dr Martens marketing 'reset' saw annual revenue and profit retreat, eyes return to growth this year
03:04am, Thursday, 05'th Jun 2025
Dr Martens PLC (LSE:DOCS) reported a 10% drop in group revenue to £787.6 million for the year ended 30 March 2025, amidst a marketing 'reset'. Adjusted profit before tax fell to £34.1 million from
The “English Warren Buffett” Dumped Most of His Portfolio, But Bought Big Into These 3 Stocks
12:26pm, Wednesday, 04'th Jun 2025
His concentrated portfolio strategy, focusing on high-quality, long-term holdings, reflects a disciplined, tech-heavy investment approach.
Doximity Rides on Telehealth Demand: Will This Drive Sales Further?
09:45am, Wednesday, 04'th Jun 2025
DOCS posts strong Q4 revenue growth and record user engagement as demand for telehealth and AI tools hits new highs.
